Vitrafy Life Sciences Enters 12-Month Deal With French Company; Shares Up 32%

MT Newswires Live
Jan 15

Vitrafy Life Sciences (ASX:VFY) entered a 12-month agreement with French company IMV Technologies to co-develop a cryopreservation offering for farm animals and aquaculture, according to a Thursday filing with the Australian bourse.

The company will earn a monthly fee of up to AU$480,000 for the duration of the agreement and may also receive milestone payments of AU$450,000 for meeting pre-determined milestones, the filing said.

The parties can extend the deal for a further six months, per the filing.

Vitrafy Life Sciences shares rose 32% in afternoon trade on Thursday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10